Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-02-26

Clinical Trial Update: Rehabilitation Study in MS Patients [Phase 4]

View source ↗

Summary

A Phase 4 rehabilitation study in relapsing-remitting multiple sclerosis sponsored by Bayer was terminated. Results from the terminated trial were posted in 201…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Bayer | Conditions: Multiple Sclerosis, Relapsing-Remitting | Phase 4 | Status: TERMINATED | Results posted: 2013-02-26